Issues related to biopharmaceutical pricing; Issues related to plasma and plasma derived therapies; Issues related to the Preserving Life-saving Access to Specialty Medicines in America Act.
Source-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 16, 2025
- Income
- $60,000.00
- Expenses
- Not reported
- Registrant
- FORBES-TATE
- Client
- CSL BEHRING
- Filing UUID
- b13b32b1-17b5-45e6-90c6-4bb0f3a9d96c
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to biopharmaceutical pricing; Issues related to plasma and plasma derived therapies; Issues related to the Preserving Life-saving Access to Specialty Medicines in America Act.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.